Lung Cancer

雜志介紹

Lung Cancer雜志介紹

《Lung Cancer》是一本以English為主的未開放獲取國際優秀期刊，中文名稱肺癌，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.5，最新CiteScore 指數為9.4。

本刊近期中國學者發表的論文主要有：

• The safety and efficacy for the treatment of alectinib in a women with ALK-positive lung cancer delivered a healthy male neonate throughout Pregnancy: A case report

  Author: Shang, Meijiao; Luo, Xi; Wu, Jingxun; Wang, ZeZheng; Chen, Qionghua; Zhou, Ying

• A novel SETD3-ALK fusion in lung adenocarcinoma and sustained clinical response to crizotinib

  Author: Dai, Shuang; Liu, Xiao-Qin; Wu, Qiang; Du, Chun-Mei; Liu, Qing; Xue, Yin-Yin; Luo, Feng; Li, Yan

• Near complete response to ceritinib in a pediatric patient with metastatic ALK-rearranged lung adenocarcinoma

  Author: Liu, Zuhui; Liu, Maolin; Hou, Xue

• One-off low-dose CT screening of positive nodules in lung cancer: A prospective community-based cohort study

  Author: Xiao, Haifan; Shi, Zhaohui; Zou, Yanhua; Xu, Kekui; Yu, Xiaoping; Wen, Lu; Liu, Yang; Chen, Haiyan; Long, Huajun; Chen, Jihuai; Liu, Yanling; Cao, Shiyu; Li, Can; Hu, Yingyun; Liao, Xianzhen; Yan, Shipeng

英文介紹

Lung Cancer雜志英文介紹

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.